You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
The firm believes that its molecular assay for the laboratory will help ease some of the supply chain issues hampering test rollout during the pandemic.
University of Oxford researchers said they are weeks away from completing clinical validation of a coronavirus molecular test based on RT-LAMP technology.
The firms are developing a testing system that involves drawing fingertip blood and doing routine testing in Babson's CLIA-certified laboratory.
Mologic says its assays could address drawbacks with lab-based molecular tests for SARS-CoV-2, such as time to results.
Labs are using specific protocols to mitigate the effects of biotin, a vitamin supplement that can interfere with test results.
Recent publications demonstrating the clinical utility of the CMV assay represent a step toward diversifying into different types of assays, the firm said.
Hologic said laboratories may leverage the random-access and open-access capabilities of its Panther Fusion system to broaden screening for the novel coronavirus.
GenMark announced on Monday that it has begun shipping its first research-use-only tests for the novel coronavirus and intends to seek emergency use authorization.
A Korean research team is developing a biosensor that boosted sensitivity by using low-cost fabrication to align high-density carbon nanotubes.
The firm said that its Affimer reagents may provide a better solution than antibodies in some applications for diagnostic test developers.